SteelPeak Wealth LLC Buys Shares of 4,274 Masimo Co. (NASDAQ:MASI)

SteelPeak Wealth LLC bought a new position in Masimo Co. (NASDAQ:MASI - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 4,274 shares of the medical equipment provider's stock, valued at approximately $570,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. NBC Securities Inc. lifted its stake in shares of Masimo by 47.1% in the 3rd quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider's stock valued at $30,000 after acquiring an additional 73 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Masimo by 75.0% during the second quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider's stock valued at $33,000 after purchasing an additional 111 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Masimo by 133.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider's stock valued at $44,000 after purchasing an additional 200 shares during the period. HHM Wealth Advisors LLC grew its holdings in shares of Masimo by 25.0% in the second quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider's stock worth $79,000 after purchasing an additional 125 shares during the last quarter. Finally, Lazard Asset Management LLC increased its stake in shares of Masimo by 5,730.0% in the first quarter. Lazard Asset Management LLC now owns 583 shares of the medical equipment provider's stock worth $85,000 after buying an additional 573 shares during the period. 85.96% of the stock is currently owned by institutional investors.

Masimo Stock Up 0.1 %

Shares of MASI stock traded up $0.21 during trading hours on Friday, hitting $144.22. 388,470 shares of the company's stock traded hands, compared to its average volume of 672,529. The company has a quick ratio of 1.15, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. The stock has a market cap of $7.67 billion, a price-to-earnings ratio of 97.97 and a beta of 0.99. The stock's fifty day simple moving average is $128.95 and its two-hundred day simple moving average is $125.27. Masimo Co. has a 12-month low of $75.36 and a 12-month high of $153.93.

Masimo (NASDAQ:MASI - Get Free Report) last released its earnings results on Tuesday, August 6th. The medical equipment provider reported $0.86 EPS for the quarter, topping the consensus estimate of $0.77 by $0.09. Masimo had a return on equity of 14.07% and a net margin of 3.94%. The business had revenue of $496.30 million for the quarter, compared to the consensus estimate of $493.92 million. During the same period in the previous year, the company posted $0.62 earnings per share. The company's revenue for the quarter was up 9.0% compared to the same quarter last year. On average, analysts expect that Masimo Co. will post 3.88 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on MASI. BTIG Research upped their target price on Masimo from $166.00 to $170.00 and gave the company a "buy" rating in a report on Monday, October 14th. Needham & Company LLC restated a "hold" rating on shares of Masimo in a report on Friday, September 20th. Finally, Piper Sandler reiterated an "overweight" rating on shares of Masimo in a report on Friday, October 18th. Four equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $145.33.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.